Printer Friendly

Intrexon subsidiary announces cooperative agreement with Gates Foundation.

Oxitec, a wholly owned subsidiary of Intrexon, announced it is entering into a cooperative agreement with the Bill & Melinda Gates Foundation to develop a new strain of Oxitec's self-limiting Friendly Mosquitoes to combat a mosquito species that spreads malaria in the Western Hemisphere. The parties will build on Oxitec's deployment of Friendly Aedes mosquitoes to reduce the vector that spreads dengue, Zika and other diseases and apply the self-limiting and male-selecting technology to anopheline vectors that can spread malaria in endemic regions in the Americas, eastern Africa and South Asia. This collaboration will fund the development of a new self-limiting Friendly Anopheles mosquito strain designed to suppress wild malaria vector populations.

COPYRIGHT 2018 The Fly
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:The Fly
Date:Jun 19, 2018
Previous Article:Platinum Group, Capricorn Municipality collaborate on water supply management.
Next Article:GameStop in focus amid 'exploratory discussions' regarding potential transaction.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters